lenvatinib and Adenosarcoma

lenvatinib has been researched along with Adenosarcoma* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and Adenosarcoma

Article	Year
Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report. Current oncology (Toronto, Ont.), 2021, 06-10, Volume: 28, Issue:3 A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her response to this treatment. Topics: Adenosarcoma; Adult; Antibodies, Monoclonal, Humanized; Female; Humans; Phenylurea Compounds; Quinolines	2021

Article

Year

Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.

Current oncology (Toronto, Ont.), 2021, 06-10, Volume: 28, Issue:3

A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her response to this treatment.

Topics: Adenosarcoma; Adult; Antibodies, Monoclonal, Humanized; Female; Humans; Phenylurea Compounds; Quinolines

2021